Follow us on
KALSIOM – The calcium signaling modulating companyKALSIOM is a biotech company based in Brest, France, discovering and developing first-in-class therapies to treat auto-immunes disorders (AID) involving B-cell dysfunction with a high medical need. The company is focusing on developing first-in-class monoclonal antibodies modulating calcium-signaling pathways in lymphocytes. The company is based on unique scientific expertise in Ca2+ signaling, combined with world-class experience in antibody development.
6 rue de Porstrein, 29200 Brest
Tél. : +33(0)2 98 46 61 34
Email : email@example.com